Datopotamab deruxtecan (DS-1062, DS-1062A, Anti-TRP2/dxd) is an antibody-drug conjugate (ADC) composed of a humanized anti-TROP2 monoclonal antibody, conjugated to topoisomerase I inhibitor, via a tetrapeptide-based linker. Datopotamab deruxtecan has a potent antitumor activity. It has average molecular weight of 146KDa. The DAR is n = 4.2. This product is for research use only.
Product Details |
Species Reactivity | Human |
---|
Type | Antibody-drug conjugate |
---|
ADC antibody | Datopotamab |
---|
ADC cytotoxin (drug) | Dxd |
---|
Immunogen | Human Topoisomerase I |
---|
DAR (Drug to Antibody Ratio) | 4.2 |
---|
Purity | 98% |
---|
Molecular Weight | 146kDa |
---|
Protein Concentration | 10mg/ml |
---|
Storage Condition | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
---|
Storage Buffer | PBS buffer pH7.4 |